Invention Application
- Patent Title: Compounds for the Treatment of Metabolic Disorders
- Patent Title (中): 化合物治疗代谢紊乱
-
Application No.: US13255531Application Date: 2010-03-12
-
Publication No.: US20120059014A1Publication Date: 2012-03-08
- Inventor: Oscar Barba , Tom Banksia Dupree , Peter Timothy Fry , Matthew Colin Thor Fyfe , Revathy Perpetua Jeevaratnam , Thomas Martin Krulle , Karen Lesley Schofield , Donald Smyth , Thomas Staroske , Alan John William Stewart , David French Stonehouse , Simon Andrew Swain , David Matthew Withall
- Applicant: Oscar Barba , Tom Banksia Dupree , Peter Timothy Fry , Matthew Colin Thor Fyfe , Revathy Perpetua Jeevaratnam , Thomas Martin Krulle , Karen Lesley Schofield , Donald Smyth , Thomas Staroske , Alan John William Stewart , David French Stonehouse , Simon Andrew Swain , David Matthew Withall
- Applicant Address: GB Oxford
- Assignee: PROSIDION LIMITED
- Current Assignee: PROSIDION LIMITED
- Current Assignee Address: GB Oxford
- Priority: GB0904285.4 20090312
- International Application: PCT/GB10/50441 WO 20100312
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D413/14 ; A61K31/4545 ; A61K31/501 ; A61P9/12 ; A61P3/04 ; A61P3/00 ; A61P3/08 ; A61P3/06 ; A61P7/00 ; C07D401/14 ; A61P3/10
Abstract:
The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
Information query
IPC分类:
